Recent research suggested that FGL1 is upregulated in gastric cancer tissues, while some studies revealed that it is downregulated and possibly acts as a tumor suppressor in hepatocellular carcinoma (18, 30). Here, FGL1 is linked to hepatocellular carcinoma.